HIV/AIDS Counseling & Testing in Maryland
Requirements for Perinatal HIV Counseling, Testing, and Referral: A Toolkit for Physicians
New regulations were approved in December 2009, following the enactment of the 2008 HIV/AIDS legislation aimed at reducing barriers to HIV testing in Maryland. A toolkit was developed by the Center in collaboration with the Infectious Disease and Environmental Health Administration, DHMH, which includes the latest information regarding HIV counseling, testing, and referral requirements in Maryland. Click here to download Perintal HIV Toolkit.
2008 Changes in HIV/AIDS Counseling and Testing Laws
Effective July 1, 2008, Maryland law has modified the HIV testing process in the areas of:
- Obtaining Informed Consent for an HIV test;
- Providing Pre-Test Counseling;
- Providing Test Results and Referrals (Post-Test Session);
- Notifying Sexual and Needle Sharing Partners; and
- Working with Pregnant Women.
It is important to note that although the Centers for Disease Control and Prevention (CDC) has issued guidelines on HIV testing in healthcare settings, those recommendations do not supersede Maryland law and regulations. If there is any incongruence between CDC's recommendations and Maryland law, State law must be followed.
Please visit the Maryland AIDS Administration's Website for more information on the Legislation.
2007 Changes in HIV/AIDS Reporting Law: What Providers Need To Know Legislation
The Maryland HIV/AIDS Reporting Act passed by the General Assembly enacts the following five changes:
- Physician reporting has been expanded from AIDS cases by name to both HIV and AIDS cases by name.
- Institutions (including hospitals, nursing homes, hospice facilities, medical clinics in correctional facilities, inpatient psychiatric facilities, and inpatient drug rehabilitation facilities) are required to report both HIV and AIDS cases by name.
- Laboratory reporting has been expanded from HIV positive tests and CD4+ lymphocyte counts 200 cells to include all CD4+ lymphocyte tests. Reporting has been changed from unique identifier code to name.
- Physician reporting has been expanded to include exposure of newborn infants to HIV. Identifying information will be removed after 18 months if the infant is found to no longer be HIV positive.
- Increased restrictions on access to HIV/AIDS data and heightened penalties for intentional release of confidential HIV/AIDS data have been added.
Effect of Proposed Changes on Health Care Providers
Physicians and health care institutions are now obligated to report all HIV and AIDS cases by name to the health department. Only complete cases, reported by name, will be counted for federal funding of local HIV prevention, care, and treatment programs. Providers are strongly encouraged to inform their patients about the changes to the reporting law, and consent must be obtained prior to HIV testing.
How to report HIV/AIDS Cases
The morbidity reporting form used by physicians, healthcare institutions, and other services providers to report all communicable diseases (DHMH Form 1140) was changed to add HIV, along with AIDS, as a reportable condition; each case report should be submitted by the provider to the local health officer within 48 hours.
Physician Toolkit: Changes in HIV/AIDS Reporting Requirements
Updated Forms
- Maryland DHMH Confidential Morbidity Reports (Instructions) (PDF)
- Maryland Confidential Morbidity Report (DHMH 1140) (PDF)
- Informed Consent and Agreement to HIV Testing (English and Spanish) (PDF)
- Perinatal HIV Authorization Form (PDF)
Patient Education Material
- Patient brochure: HIV/AIDS Reporting (PDF)
- Patient brochure: Partner Counseling and Referral Services (PDF)
Additional HIV/AIDS Materials
- Maryland Epidemiological Profile (PDF)
- HHS Fact Sheet: Testing HIV Positive - Do I have AIDS?
- Centers for Disease Control and Prevention
- CDC HIV/AIDS Fact Sheet (PDF)
For more information about the changes to HIV reporting, visit:
Preventing Perinatal HIV Transmission
In past years, an estimated 92% of AIDS cases reported among children less than 13 years old in the US, were attributed to perinatal or mother-to-child transmission of HIV. Transmission can occur during pregnancy, labor, delivery or breastfeeding. Recent reductions in perinatal transmission are attributed to routine screening of pregnant women to identify those infected with HIV and the use of anti-retroviral drugs for treatment and prophylaxis. Rates of HIV transmission from an infected mother to her infant have been reduced to less than 2%, compared to 25%-30% with no interventions. The Baltimore Regional Perinatal Advisory Group (RPAG) works to optimize the health of pregnant women and newborn infants in the Baltimore region through education, advocacy and information sharing. RPAG has developed “Preventing Perinatal HIV Transmission: A Clinician’s Toolkit for Testing Counseling and Referral.”
Resources
- Preventing Perinatal HIV Transmission: A Clinician’s Toolkit for Testing Counseling and Referral
- CDC’s Perinatal HIV/AIDS Fact Sheet
- Centers for Disease Control and Prevention
Contact Information
For more information on HIV/AIDS Counseling and Testing in Maryland, please contact:
Erin Johnson , M.P.H.
Program Coordinator
Phone: 410-539-0872 or 800-492-1056, ext. 3342
Fax: 410-649-4131
Email: ejohnson@medchi.org
Last Updated 7/6/2010

2008 Changes in HIV/AIDS Counseling and Testing Laws:
Practice Advisory
Infectious Disease and Environmental Health Administration, DHMH Website
2007 Physician toolkit on changes to HIV/AIDS
reporting law


